Major histocompatibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes: Analysis of tumor susceptibility to NKG2D-dependent natural killer cell cytotoxicity

Cancer Research

Volumn 62, Issue 21, 2002, Pages 6178-6186

  Pende, Daniela ^a   Rivera, Paola ^b   Marcenaro, Stefania ^c   Chang, Chien Chung ^d   Biassoni, Roberto ^a   Conte, Romana ^a   Kubin, Marek ^e   Cosman, David ^e   Ferrone, Soldano ^d   Moretta, Lorenzo ^b,c   Moretta, Alessandro ^b  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c G GASLINI INSTITUTE   (Italy)

^d ROSWELL PARK CANCER INSTITUTE   (United States)

^e AMGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; CELL RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MONOCLONAL ANTIBODY; NATURAL KILLER CELL RECEPTOR NKG2D; PROTEIN UL16; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; B CELL LYMPHOMA; CANCER SUSCEPTIBILITY; CARCINOMA CELL; CELL KILLING; CONTROLLED STUDY; HUMAN; HUMAN CELL; MELANOMA CELL; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; T CELL LEUKEMIA; TARGET CELL; TUMOR CELL LINE;

CARRIER PROTEINS; CYTOTOXICITY, IMMUNOLOGIC; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; KILLER CELLS, NATURAL; LEUKEMIA; MELANOMA; NEOPLASMS; NEUROBLASTOMA; RECEPTORS, IMMUNOLOGIC; TUMOR CELLS, CULTURED;

EID: 0036829733     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Trinchieri, G. Biology of natural killer cells. Adv. Immunol., 47: 187-376, 1990.
2. Biron, C. A. Activation and function of natural killer cell responses during viral infections. Curt. Opin. Immunol., 9: 24-34 1997.
3. Ljunggren, H-G., and Karre, K. In search of the "missing self." MHC molecules and NK cell recognition. Immunol. Today. 11: 237-244, 1990.
4. Moretta, A., Bottino, C., Vitale, M, Pende, D., Biassoni, R., Mingari, M. C., and Moretta, L., Receptors for HLA-class I molecules in human natural killer cells. Annu. Rev. Immunol., 14: 619-648, 1996.
5. Moretta, A., Biassoni, R., Bottino, C., Pende, D., Vitale, M., Poggi, A., Mingari, M. C., and Moretta, L. Major histocompatibility complex class I-specific receptors on human natural killer and T lymphocytes. Immunol. Rev., 155: 105-117, 1997.
6. Lanier, L. L. NK cell receptors. Annu. Rev. Immunol., 16: 359-393, 1998.
7. Long, E. O. Regulation of immune responses through inhibitory receptors. Annu. Rev. Immunol., 17: 875-904, 1998.
8. Lanier, L. L. Turning on natural killer cells. J. Exp. Med., 191: 1259-1262, 2000.
9. Biassoni, R., Cantoni, C., Pende, D., Sivori, S., Parolini, S., Vitale, M., Bottino, C., Moretta, A. Human natural killer cell receptors and co-receptors. Immunol. Rev., 181: 203-214, 2001.
10. Moretta, A., Bottino, C., Vitale, M. Pende. D., Cantoni, C., Mingari, M. C., Biassoni, R., and Moretta, L. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu. Rev. Immunol., 19: 197-223, 2001.
11. Sivori, S., Vitale, M., Morelli, L., Sanseverino, L., Augugliaro, R., Bottino, C., Moretta, L., and Moretta, L. p46, a novel natural killer cell-specific surface molecule which mediates cell activation. J. Exp. Med., 186: 1129-1136, 1997.
12. Pessino, A., Sivori, S., Bottino, C., Malaspina, A., Morelli, L., Moretta, L., Biassoni, R., and Moretta, A. Molecular cloning of NKp46: a novel member of the immunoglobulin superfamily involved in triggering of natural cytotoxicity. J. Exp. Med., 188: 953-960, 1998.
13. Vitale, M., Bottino, C., Sivori, S., Sanseverino, L., Castriconi, R., Marcenaro, E., Augugliaro, R., Moretta, L., and Moretta, A. NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells is involved in nonMHC restricted tumor cell lysis. J. Exp. Med., 187: 2065-2072, 1998.
14. Cantoni, C., Bottino. C., Vitale, M., Pessino, A., Augugliaro, R., Malaspina, A., Parolini, S., Moretta, L., Moretta, A., and Biassoni, R. NKp44, a triggering receptor involved in tumor cell lysis by activated human natural killer cells is a novel member of the immunoglobulin superfamily. J. Exp. Med., 189: 787-796, 1999.
15. Pende, D., Parolini, S., Pessino, A., Sivori, S., Augugliaro, R., Morelli, L., Marcenaro, E., Accame, A., Malaspina, R., Biassoni, C., Bottino. L., Moretta, L., and Moretta, A. Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells. J. Exp. Med., 190: 1505-1516, 1999.
16. Moretta, A., Biassoni, R., Bottino, C., Mingari, M. C., and Moretta, L. Natural cytotoxicity receptors that trigger human NK-mediated cytolysis. Immunol. Today. 21: 228-234, 2000.
17. Sivori, S., Pende, D., Bottino, C., Marcenaro, E., Pessino, A., Biassoni, R., Moretta, L., and Moretta, A. NKp46 is the major triggering receptor involved in the natural cytotoxicity of fresh or cultured human natural killer cells. Correlation between surface density of NKp46 and natural cytotoxicity against autologous, allogeneic or xenogeneic target cells. Eur. J. Immunol., 29: 1656-1666, 1999.
18. Mandelboim, O., Lieberman, N., Lev, M., Paul, L., Amon, T. I., Bushkin, Y., Davis, D. M., Strominger, J. L., Yewdell, J. W., and Porgador, A. Recognition of hemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells. Nature (Lond.), 409: 1055-1060, 2001.
19. Amon, T. I., Lev, M., Katz, G., Chemobrov, Y., Porgador, A., and Mandelboim, O. Recognition of viral hemagglutinin by NKp44 but not by NKp30. Eur. J. Immunol., 9: 2680-2689, 2001.
20. Bauer, S., Groh, V., Wu, J., Steinle, A., Phillips, J. H., Lanier, L. L., and Spies, T., Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science (Wash. DC), 285: 727-729, 1999.
21. Wu, J., Song, Y., Bakker, A. B. H., Bauer, S., Spies, T., Lanier, L. L., and Phillips, J. H. An activating immunoreceptor complex formed by NKG2D and DAP 10. Science (Wash. DC), 285: 730-732, 1999.
22. Pende, D., Cantoni, C., Rivera, P., Vitale, M., Castriconi, R., Marcenaro, S., Nanni, M., Biassoni, R., Bortino, C., Morerta, A., and Moretta, L. Role of NKG2D in tumor cell lysis mediated by human NK cells: Cooperation with natural cytotoxicity receptors and capability of recognizing tumors of nonepithelial origin. Eur. J. Immunol., 31: 1076-1086, 2001.
23. Chang, C., Dietrich, J., Harpur, A. G., Lindquist, J. A., Haude, A., Loke, Y. W., King, A., Colonna, M., Trowsdale, J., and Wilson, M. J. KAP10, a novel transmembrane adapter protein genetically linked to DAP12 but with unique signaling properties. J. Immunol., 163: 4651-4654, 1999.
24. Wu, J., Cherwinski, H., Spies, T., Philips, J. H., and Lanier, L. L. DAP10 and DAP12 form distinct, but functionally cooperative, receptor complexes in NK cells. J. Exp. Med., 192: 1059-1067, 2000.
25. Li, P., Morris, D. L., Willcox, B. E., Steinle, A., Spies, T., and Strong, R. K. Complex structure of the activating immunoreceptor NKG2D and its MHC class I-like ligand MICA. Nat. Immunol., 2: 443-451, 2001.
26. Groh, V., Bahram, S., Bauer, S., Herman, A., Beauchamp, M., and Spies, T. Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium. Proc. Natl. Acad. Sci. USA, 93: 12445-12450, 1996.
27. Groh, V., Steinle, A., Bauer, S., and Spies, T. Recognition of stress-induced MHC molecules by intestinal epithelial γδ T cells. Science (Wash. DC). 279: 1737-1740, 1998.
28. Groh, V., Rhinehart, R., Secrist, H., Bauer, S., Grabstein, K. H., and Spies, T. Broad tumor-associated expression and recognition by tumor-derived γδT cells of MICA and MICB. Proc. Natl. Acad. Sci. USA, 96: 6879-6884, 1999.
29. Vetter, C. S., Groh, V., Straten, P. P., Spies, T., Brocker, E. B., and Becker, J. C. Expression of stress-induced MHC class 1 related chain molecules on human melanoma. J. Investig. Dermatol., 118: 600-605, 2002.
30. Cosman, D., Mulberg, J., Sutherland, C., Chin, W., Armitage, R., Fanslow, W., Kubin, M., and Chalupny, J. ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor. Immunity, 14: 123-133, 2001.
31. Sutherland, C., Chalupny, J., and Cosman, D. The UL16-binding proteins, a novel family of MHC class I-related ligands for NKG2D, activate natural killer cell functions. Immunol. Rev., 181: 185-192, 2001.
32. Sutherland, C., Chalupny, J., Schooley, K., Vandenbos, T., Kubin, M., and Cosman, D. UL16-binding proteins, novel MHC class I-related proteins, bind to NKG2D and activate multiple signaling pathways in primary NK cells. J. Immunol., 168: 671-679, 2002.
33. Diefenbach, A., Jamieson, A. M., Liu, S. D., Shastri, N., and Raulet, D. H. Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages. Nat. Immunol., 1: 119-126, 2000.
34. Cerwenka, A., Bakker, A. B. H., McClanahan, T., Wagner, J., Wu, J., Phillips, J. H., and Lanier, L. L. Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice. Immunity, 12: 721-727, 2000.
35. Diefenbach, A., Jensen, E. R., Jamieson, A. M., and Raulet, D. H. Rael and H60 ligands of the NKG2D receptor stimulate tumor immunity. Nature (Lond.), 413: 165-171, 2001.
36. Hicklin, D. J., Wang, Z., Arienti, F., Rivoltini L., Parmiani, G., and Ferrone S. β2-Microglobulin mutations. HLA class I antigen loss, and tumor progression in melanoma. J. Clin. Investig., 101: 2720-2729, 1998.
37. Wang, Z., Cao, Y., Albino, A. P., Zeff, R. A., Houghton, A., and Ferrone, S., Lack of HLA class I antigen expression by melanoma cells SK-MEL-33 caused by a reading frameshift in β2-microglobulin messenger RNA. J. Clin. Investig., 91: 684-692, 1993.
38. D’Urso, C. M., Wang, Z. G., Cao, Y., Tatake, R., Zeff, R. A., and Ferrone, S. Lack of HLA class 1 antigen expression by cultured melanoma cells FO-1 due to a defect in B2m gene expression. J. Clin. Investig., 87: 284-292, 1991.
39. Restifo, N. P., Marincola, F. M., Kawakami, Y., Taubenberger, J., Yannelli, J, R., and Rosenberg, S. A. Loss of functional β2-microglobulin in metastatic melanomas from five patients receiving immunotherapy. J. Natl. Cancer Inst., 88: 100-108, 1996.
40. Cattel, L., Delprino, L., Brusa, P., Dosio, F., Comoglio, P. M., and Prat, M. Comparison of blocked and non-blocked ricin-antibody immunotoxins against human gastric carcinoma and colorectal adenocarcinoma cell lines. Cancer Immunol. Immunother., 27: 233-240, 1988.
41. Sulit, H. L., Golub, S. H., Irie, R. F., Gupta, R, K., Grooms, G. A., and Morton, D. L. Human tumor cells grown in fetal calf serum and human serum: Influences on the tests for lymphocyte cytotoxicity, serum blocking and serum arming effects. Int. J. Cancer, 17: 461-468, 1976.
42. Pende, D., Accame, L., Pareti, L., Mazzocchi, A., Moretta, A., Parmiani, G., and Moretta, L. The susceptibility to natural killer-mediated lysis of HLA class 1-positive melanomas reflects the expression of insufficient amounts of different HLA class 1 alleles. Eur. J, Immunol., 28: 2384-2394, 1998.
43. Ikeda, H., Lethé, B., Lehmann, F., Van Baren, N., Baurain, J. F., De Smet, C., Chambost, H., Vitale, M., Moretta, A., and Boon, T. Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor. Immunity, 6: 199-208, 1997.
44. Stacchini, A., Aragno, M., Vallario, A., Alfarano, A., Circosta, P., Gottardi, D., Faldella, A., Rege-Cambrin, G., Thunberg, U., Nilsson, K., and Calligaris-Cappio, F. MEC1 and MEC2: two new cell lines derived from B-chronic lymphocytic leukemia in prolymphocytoid transformation. Leuk. Res., 23: 127-136, 1999.
45. Algar, E. M., Khromykh, T., Smith, S. I., Blackburn, D. M., Bryson, G, J., and Smith, P. J. A. WTI anti-sense oligonucleotide inhibits proliferation and induces apoptosis in myeloid leukemia cell lines. Oncogene, 12: 1005-1014, 1996.
46. Bénard, J. De Silva, J., De Blois, M. C., Boyer, P., Duvillard, P., Chiric, E., and Riou, G. Characterization of a human ovarian adenocarcinoma line, IGROVI, in tissue culture and in nude mice. Cancer Res., 45: 4970-4979, 1985.
47. Spaggiari, M. G., Carosio, R., Pende, D., Marcenaro, S., Rivera, P., Zocchi, M. R., Moretta, L., and Poggi, A. NK cell mediated lysis of autologous antigen-presenting cells is triggered by the engagement of the phosphatidylinositol 3-kinase upon ligation of the natural cytotoxicity receptors NKp30 and NKp46. Eur. J. Immunol., 31: 1656-1665, 2001.
48. Li, Z., Groh, V., Strong, R. K., and Spies T. A single amino acid substitution causes loss of expression of a MICA allele, Immunogenetics, 51: 246-248, 2000.
49. Sivori, S., Parolini, S., Marcenaro, E., Castriconi, R., Pende, D., Millo, R., and Moretta, A. Involvement of natural cytotoxicity receptors in human natural killer cell-mediated lysis of neuroblastoma and glioblastoma cell lines. J. Neuroimmunol., 107: 220-225, 2000.
50. Costello, R. T., Sivori, S., Marcenaro, E., Reviron, D., Gastaut, J. A., Pende, D., Olive, D., and Moretta, A. Defective expression and function of natural killer cell triggering receptors in patients with acute myeloid leukemia. Blood, 99: 3661-3667, 2002.